Literature DB >> 11104723

Monocyte chemoattractant protein-1 and RANTES are chemotactic for graft infiltrating lymphocytes during acute lung allograft rejection.

Y Sekine1, K Yasufuku, K M Heidler, O W Cummings, N Van Rooijen, T Fujisawa, J Brown, D S Wilkes.   

Abstract

Graft infiltrating lymphocytes (GILs) are crucial to rejection of lung allografts. However, chemotactic activities, chemokines responsible for GIL recruitment, and cells involved in chemokine production during lung allograft rejection have not been evaluated. This study determined whether chemotactic activity for GILs is upregulated, and whether the chemokines monocyte chemoattractant protein (MCP)-1 and regulated on activation, normal T cells expressed and secreted (RANTES) have roles in GIL chemotaxis during lung allograft rejection. F344 (RT1(lv1)) rat lung allografts were transplanted into WKY (RT1(l)) recipients. Chemotactic activity for GILs and quantities of MCP-1 and RANTES were determined in allograft bronchoalveolar lavage fluid 1 wk after transplantation. Data showed that during rejection, chemotactic activity for GILs is upregulated, MCP-1 and RANTES are produced locally, and both MCP-1 and RANTES are operative in GIL recruitment. Immunohistochemistry showed that alveolar macrophages (AMs) were the major source of MCP-1 and that other lung cells, including AMs, were the source of RANTES. Further, depletion of AMs in the donor lung before transplantation downregulated chemotaxis for GILs and production of MCP-1 during rejection episodes. These data show that chemotaxis for GILs is upregulated locally during lung allograft rejection, and that MCP-1 and RANTES contribute to GIL recruitment during the rejection response.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11104723     DOI: 10.1165/ajrcmb.23.6.3825

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  12 in total

Review 1.  Human and murine obliterative bronchiolitis in transplant.

Authors:  John F McDyer
Journal:  Proc Am Thorac Soc       Date:  2007-01

2.  Changes of inducible protein-10 and regulated upon activation, normal T cell expressed and secreted protein in acute rejection of pancreas transplantation in rats.

Authors:  Jun Zhu; Ze-Kuan Xu; Yi Miao; Xun-Liang Liu; Hong Zhang
Journal:  World J Gastroenterol       Date:  2006-07-14       Impact factor: 5.742

3.  Impact of MHC class II incompatibility on localization of mononuclear cell infiltrates to the bronchiolar compartment of orthotopic lung allografts.

Authors:  Shinji Nakashima; T Rinda Soong; Karen Fox-Talbot; Zhiping Qian; Salma Rahimi; Barbara A Wasowska; Charles A Rohde; Sabrina Chen; Joe G N Garcia; William M Baldwin
Journal:  Am J Transplant       Date:  2005-04       Impact factor: 8.086

4.  The potassium channel KCa3.1 as new therapeutic target for the prevention of obliterative airway disease.

Authors:  Xiaoqin Hua; Tobias Deuse; Yi-Je Chen; Heike Wulff; Mandy Stubbendorff; Ralf Köhler; Hiroto Miura; Florian Länger; Hermann Reichenspurner; Robert C Robbins; Sonja Schrepfer
Journal:  Transplantation       Date:  2013-01-27       Impact factor: 4.939

5.  Alloimmune lung injury induced by local innate immune activation through inhaled lipopolysaccharide.

Authors:  Stavros Garantziotis; Scott M Palmer; Laurie D Snyder; Tonya Ganous; Benny J Chen; Tie Wang; Donald N Cook; David A Schwartz
Journal:  Transplantation       Date:  2007-10-27       Impact factor: 4.939

6.  C4d deposition and cellular infiltrates as markers of acute rejection in rat models of orthotopic lung transplantation.

Authors:  Kazunori Murata; Takekazu Iwata; Shinji Nakashima; Karen Fox-Talbot; Zhiping Qian; David S Wilkes; William M Baldwin
Journal:  Transplantation       Date:  2008-07-15       Impact factor: 4.939

7.  CCR1/CCL5 (RANTES) receptor-ligand interactions modulate allogeneic T-cell responses and graft-versus-host disease following stem-cell transplantation.

Authors:  Sung W Choi; Gerhard C Hildebrandt; Krystyna M Olkiewicz; David A Hanauer; Meghana N Chaudhary; Ines A Silva; Clare E Rogers; Daphne T Deurloo; Jacki M Fisher; Chen Liu; David Adams; Stephen W Chensue; Kenneth R Cooke
Journal:  Blood       Date:  2007-07-19       Impact factor: 22.113

8.  Methemoglobin-induced signaling and chemokine responses in human alveolar epithelial cells.

Authors:  Sharon Mumby; Latha Ramakrishnan; Timothy W Evans; Mark J D Griffiths; Gregory J Quinlan
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-10-18       Impact factor: 5.464

9.  Type V collagen-induced oral tolerance plus low-dose cyclosporine prevents rejection of MHC class I and II incompatible lung allografts.

Authors:  Yoshito Yamada; Yasuo Sekine; Shigetoshi Yoshida; Kazuhiro Yasufuku; Irina Petrache; Heather L Benson; David D Brand; Ichiro Yoshino; David S Wilkes
Journal:  J Immunol       Date:  2009-07-01       Impact factor: 5.422

Review 10.  Chemokines and transplant vasculopathy.

Authors:  John A Belperio; Abbas Ardehali
Journal:  Circ Res       Date:  2008-08-29       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.